367 p. : 25 cm. --
Strategic Nuclear Targeting
โ Scribed by Desmond Ball (editor); Jeffrey Richelson (editor)
- Publisher
- Cornell University Press
- Year
- 2019
- Tongue
- English
- Leaves
- 361
- Category
- Library
No coin nor oath required. For personal study only.
โฆ Synopsis
This collection of essays by thirteen academic and professional strategists seeks to close this gap by addressing the basic issues of nuclear targeting policy: the targets to be attacked, the timing of those attacks, and the intended impact of the targeting strategy.
๐ SIMILAR VOLUMES
<p>In what Stanley Hoffmann, writing in <i>The New York Review of Books</i>, has called a "fine analysis and critique of American targeting policies," Sagan looks more at the operational side of nuclear strategy than previous analysts have done, seeking to bridge the gap between theory and practice.
For decades, the reigning scholarly wisdom about nuclear weapons policy has been that the United States only needs the ability to absorb an enemy nuclear attack and still be able to respond with a devastating counterattack. So long as the US, or any other nation, retains such an assured retaliation
"What kind of nuclear strategy and posture does the United States need to defend itself and its allies? According to a longstanding, academic conventional wisdom, the answer to this question is straightforward: the United States needs the ability to absorb an enemy nuclear attack and respond with a
G protein-coupled receptors (GPCRs) are one of the most important target classes in pharmacology and are the target of many blockbuster drugs. Yet only with the recent elucidation of the rhodopsin structure have these receptors become amenable to a rational drug design. <p> Based on recent exa